UB Paderborn / Katalog / Suche / in CDI

1 – 10 von 10

Sortiert nach

Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy

Cytotherapy (Oxford, England), 2017-07, Vol.19 (7), p.784-797

2017

Volltextzugriff (PDF)

Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.856

2007

Volltextzugriff (PDF)

Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy

Cytotherapy (Oxford, England), 2018-05, Vol.20 (5), p.601-622

2018

Volltextzugriff (PDF)

Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication

Antiviral research, 2003-05, Vol.58 (3), p.253-263

2003

Volltextzugriff (PDF)

Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy

Cytotherapy (Oxford, England), 2018-11, Vol.20 (11), p.1289-1308

2018

Volltextzugriff (PDF)

A structured approach to Exposure Based Waiving of human health endpoints under REACH developed in the OSIRIS project

Regulatory toxicology and pharmacology, 2012-03, Vol.62 (2), p.231-240

2012

Volltextzugriff (PDF)

Exposure-based waiving under REACH

Regulatory toxicology and pharmacology, 2010-12, Vol.58 (3), p.408-420

2010

Volltextzugriff (PDF)

Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu

Toxicological sciences, 2005-05, Vol.85 (1), p.632-638

2005

Volltextzugriff (PDF)

Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro

Journal of hepatology, 2006-11, Vol.45 (5), p.696-703

2006

Volltextzugriff (PDF)

APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro

Journal of antimicrobial chemotherapy, 2003-05, Vol.51 (5), p.1181-1189

2003

Volltextzugriff (PDF)

1 – 10 von 10

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(10)

Sprache

Englisch
(10)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(6)
Pharmacology & Pharmacy
(5)
Animals
(4)
Advanced Basic Science
(3)
Biological And Medical Sciences
(3)
Biotechnology & Applied Microbiology
(3)
Cell & Tissue Engineering
(3)
Cell Biology
(3)
Government Regulation
(3)
Hematology
(3)
In Vitro Potency Assays
(3)
Male
(3)
Medical Sciences
(3)
Medicine, Research & Experimental
(3)
Other
(3)
Pharmacology. Drug Treatments
(3)
Quality Control
(3)
Rats
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy

Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells

Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy

Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication

Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy

A structured approach to Exposure Based Waiving of human health endpoints under REACH developed in the OSIRIS project

Exposure-based waiving under REACH

Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu

Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro

APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro

Suchergebnisse filtern